Reasoning
The PTEN VCEP permits PS4 from either phenotype-specificity scores or a sufficiently powered case-control study. The available case record provides no Cleveland Clinic or pediatric phenotype scores, affected-proband count, unaffected-control count, odds ratio, confidence interval, p-value, or other case-control data for NM_000314.8:c.147del. The literature packet contains no AI-classified PS4 papers, and the only extracted full-text paper (PMID:26467025) does not mention c.147del or provide PTEN-specific case observations, phenotype data, or population comparisons. Therefore the VCEP rule cannot be evaluated; PS4 is not assessed.
VCEP rule
Probands with specificity score 4-15.5 (see text) OR The prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls.
Evidence considered
- ClinGen PTEN VCEP specification v3.2, PS4 instructions: a sufficiently powered case-control study may qualify when odds ratio >2 for a PHTS component phenotype, p<0.05, and the 95% confidence-interval lower limit >1.5; alternatively, phenotype-specificity scores are summed across independent probands.
- literature_pass.json: ai_classified_papers is empty and no PS4 paper was screened as variant-specific.
- PMID:26467025 paper_extracts.json: the paper does not mention PTEN c.147del / p.(N49Kfs*5) and reports no PTEN-specific case observations, phenotype data, segregation data, or population frequency for this variant.
Still missing
- Obtain independent-proband Cleveland Clinic or pediatric phenotype scores, or a sufficiently powered affected-versus-control study reporting counts or an odds ratio with 95% confidence interval and p-value.
Sources